CCL2 and neoplasm: Mechanistically, when these mast cells migrate to tumors, they augment the interaction between estrogen receptors (ERs) and C–C Motif Chemokine Ligand 2 (CCL2), with CCL2 promoting EMT and matrix metalloproteinase (MMP) synthesis at the tumor site [100].